Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions.
作者信息
Gonzalez-Cuevas Gustavo, Garcia-Gutierrez Maria S, Navarrete Francisco, de Guglielmo Giordano, Manzanares Jorge
机构信息
Department of Clinical Psychopharmacology, College of Pharmacy, Idaho State University, Meridian, ID, United States.
Instituto de Neurociencias Universidad Miguel Hernandez-CSIC, San Juan de Alicante, Spain.
出版信息
Front Pharmacol. 2021 Oct 18;12:752292. doi: 10.3389/fphar.2021.752292. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions.社论：神经治疗干预中的大麻二酚治疗
Front Pharmacol. 2021 Oct 18;12:752292. doi: 10.3389/fphar.2021.752292. eCollection 2021.
2
Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II.社论：神经治疗干预中的大麻二酚治疗，第二卷。
Front Pharmacol. 2023 Feb 23;14:1163991. doi: 10.3389/fphar.2023.1163991. eCollection 2023.
3
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.大麻二酚（CBD）在神经精神障碍中的作用：临床前和临床研究结果综述。
Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28.
4
Cannabidiol, neuroprotection and neuropsychiatric disorders.大麻二酚、神经保护与神经精神疾病
Pharmacol Res. 2016 Oct;112:119-127. doi: 10.1016/j.phrs.2016.01.033. Epub 2016 Feb 1.
5
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment.大麻二酚：神经精神疾病治疗的最新进展和新见解。
Life Sci. 2019 May 1;224:120-127. doi: 10.1016/j.lfs.2019.03.053. Epub 2019 Mar 22.
6
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.大麻二酚：治疗焦虑、抑郁和精神障碍的新选择。
Biomolecules. 2020 Nov 19;10(11):1575. doi: 10.3390/biom10111575.
7
Cannabidiol in Anxiety and Sleep: A Large Case Series.大麻二酚在焦虑和睡眠方面的研究：一项大型病例系列研究
Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041.
8
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.大麻二酚作为焦虑和心境障碍的潜在治疗方法：来自临床前研究的分子靶点和表观遗传学见解。
Int J Mol Sci. 2021 Feb 13;22(4):1863. doi: 10.3390/ijms22041863.
9
Cannabidiol effects on prepulse inhibition in nonhuman primates.大麻二酚对非人类灵长类动物前脉冲抑制的影响。
Rev Neurosci. 2018 Dec 19;30(1):95-105. doi: 10.1515/revneuro-2017-0101.
10
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.大麻二酚对认知功能影响的系统评价：与精神分裂症的相关性。
Neurosci Biobehav Rev. 2017 Jan;72:310-324. doi: 10.1016/j.neubiorev.2016.11.012. Epub 2016 Nov 22.
引用本文的文献
1
Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats.大麻二酚对老年大鼠的剂量依赖性抗抑郁样作用。
Front Pharmacol. 2022 Jul 1;13:891842. doi: 10.3389/fphar.2022.891842. eCollection 2022.
2
Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective.探索青少年抑郁症的药理学治疗方案：基于性别视角的临床前评估
Transl Psychiatry. 2022 Jun 1;12(1):220. doi: 10.1038/s41398-022-01994-y.
本文引用的文献
1
Cannabidiol: pharmacology and therapeutic targets.大麻二酚：药理学与治疗靶点。
Psychopharmacology (Berl). 2021 Jan;238(1):9-28. doi: 10.1007/s00213-020-05712-8. Epub 2020 Nov 21.
2
[Not Available].[无可用内容]
Can J Psychiatry. 2020 Apr;65(4):213-227. doi: 10.1177/0706743719895195. Epub 2019 Dec 13.
3
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.使用医用和消费级大麻二酚（CBD）时潜在的药物不良事件和药物相互作用。
J Clin Med. 2019 Jul 8;8(7):989. doi: 10.3390/jcm8070989.
4
Cannabidiol Adverse Effects and Toxicity.大麻二酚的不良反应和毒性。
Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901.
5
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.大麻二酚在人体中药代动力学的系统评价。
Front Pharmacol. 2018 Nov 26;9:1365. doi: 10.3389/fphar.2018.01365. eCollection 2018.
6
Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.大麻二酚作为创伤后应激障碍的一种治疗选择：从基础研究到人体试验的确证
Front Neurosci. 2018 Jul 24;12:502. doi: 10.3389/fnins.2018.00502. eCollection 2018.
7
Cannabidiol does not display drug abuse potential in mice behavior.大麻二酚在小鼠行为中不表现出滥用药物的潜力。
Acta Pharmacol Sin. 2019 Mar;40(3):358-364. doi: 10.1038/s41401-018-0032-8. Epub 2018 Jul 18.
8
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.大麻二酚预防药物滥用复发的独特治疗潜力：临床前原理验证。
Neuropsychopharmacology. 2018 Sep;43(10):2036-2045. doi: 10.1038/s41386-018-0050-8. Epub 2018 Mar 22.
9
Urgent Need for Improved Mental Health Care and a More Collaborative Model of Care.迫切需要改善精神卫生保健及采用更具协作性的护理模式。
Perm J. 2017;21:17-024. doi: 10.7812/TPP/17-024.
10
Cannabidiol reduces ethanol consumption, motivation and relapse in mice.大麻二酚可减少小鼠的乙醇摄入量、饮酒动机和复饮。
Addict Biol. 2018 Jan;23(1):154-164. doi: 10.1111/adb.12495. Epub 2017 Feb 13.
Zotero 插件